Pharmaceutical

Cancer Research UK and CRIS fund lung cancer vaccine research

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

Mar 26, 2024 - 00:00
Cancer Research UK and CRIS fund lung cancer vaccine research
Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.
Read the original article

Tags:

Previous Article

FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension

Next Article

FDA approves Takeda’s Iclusig for Philadelphia chromosome-positive ALL

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data

Dana-Farber expands studies to be retracted to 6, plus ...

Jan 22, 2024

U.S. government spent more on health care in 2022 than six countries with universal health care combined

U.S. government spent more on health care in 2022 than ...

Dec 19, 2023

EMA CHMP recommends Takeda’s Hyqvia for CIDP treatment

EMA CHMP recommends Takeda’s Hyqvia for CIDP treatment

Dec 18, 2023